Foundation Fighting Blindness
Foundation Fighting Blindness
Add to My Podcasts
Episodes
About
Reviews
Promote
SparingVision Receives Authorization to Launch US Clinical Trial for its Cone-Preserving Treatment
2 minutes
Posted Dec 2, 2022 at 8:35 pm.
0:00
2:52
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
The emerging therapy is designed to work independent of the mutated gene causing retinitis pigmentosa
Previous
News | Opus Genetics to Launch Gene Therapy Clinical Trial for LCA5 Patients
Next
Eye on the Cure Podcast | Episode 37: Rando Allikmets, PhD
← See all 261 episodes of Foundation Fighting Blindness